Sun Pharmaceutical Industries Ltd vs Divis Laboratories Ltd
SUNPHARMA vs DIVISLAB — Side-by-side fundamental comparison
SUNPHARMA
Sun Pharmaceutical Industries Ltd
₹1905.80
+1.47%
Score: 65.20/100
DIVISLAB
Divis Laboratories Ltd
₹6835.00
+1.10%
SUNPHARMA
Metric
DIVISLAB
| 65.20/100 | Bull Run Score | ✓🔒 Premium |
| 434K✓ | Market Cap (₹ Cr) | 170K |
| 37.57x✓ | P/E Ratio | 68.59x |
| 16.86%✓ | Return on Equity | 15.35% |
| 20.21% | ROCE | ✓20.44% |
| 0.07 | Debt/Equity | ✓0.01 |
| 0.89%✓ | Dividend Yield | 0.47% |
| 9.87% | Sales Growth 5Y | ✓11.65% |
| 23.78%✓ | Profit Growth 5Y | 10.41% |
| 54.48%✓ | Promoter Holding | 51.89% |
| 1.49% | 1Y Return | ✓4.05% |
| 31.77x | Industry P/E | 31.77x |
Sun Pharmaceutical Industries Ltd vs Divis Laboratories Ltd — Key Takeaways
Sun Pharmaceutical Industries Ltd (SUNPHARMA) has a Bull Run fundamental score of 65.20/100 compared to 67.90/100 for Divis Laboratories Ltd (DIVISLAB). SUNPHARMA trades at a lower P/E of 37.57x vs 68.59x for DIVISLAB. In terms of profitability, SUNPHARMA has a higher ROE of 16.86% vs 15.35% for DIVISLAB. This comparison is for educational purposes only. Please consult a SEBI-registered financial advisor before investing.
Data from NSE/BSE filings. Educational only. Not investment advice. Bull Run is not SEBI-registered.